Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
← Research & Industry News
External source

Gene therapy that led to boy’s death had limited efficacy

Therapy pioneered by biotechnology Chinese firm HuidaGene showed promise in animals but caused a fatal reaction in a child.

Published by
Nature
Evidence type
Laboratory

Therapy pioneered by biotechnology Chinese firm HuidaGene showed promise in animals but caused a fatal reaction in a child.

This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at Nature.

Gene therapy that led to boy’s death had limited efficacy | Brilliant Blue Biosciences